SAFETY AND EFFECTIVENESS OF PEMETREXED IN PATIENTS WITH NON-SMALL CELL LUNG CANCER IN JAPAN BASED ON POST-MARKETING SURVEILLANCE

被引：0
|
作者：
Okubo, Sumiko [1 ]
Kobayashi, Noriko [1 ]
Taketsuna, Masanori [1 ]
Enatsu, Sotaro [1 ]
Nishiuma, Shinichi [1 ]
机构：
[1] Eli Lilly Japan, Kobe, Hyogo, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2012年 / 7卷 / 11期
关键词：
Post-Marketing Surveillance; NSCLC; Pemetrexed;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-011
引用
收藏
页码：S485 / S485
页数：1
相关论文
共 50 条
  • [31] ECONOMIC EVALUATION OF PEMETREXED IN PATIENTS WITH PREVIOUSLY TREATED ADVANCED NON-SMALL CELL LUNG CANCER IN JAPAN
    Kamae, I
    Nakahara, N.
    Moriwaki, K.
    Enatsu, S.
    Nambu, Y.
    [J]. VALUE IN HEALTH, 2010, 13 (07) : A513 - A513
  • [32] Pemetrexed in the treatment of non-small cell lung cancer
    Shepherd, FA
    [J]. SEMINARS IN ONCOLOGY, 2002, 29 (06) : 43 - 48
  • [33] Safety and Effectiveness Analysis of Dolutegravir in Patients with HIV-1: Interim Report of Post-Marketing Surveillance in Japan
    Haruyuki Hongo
    Takako Nagao
    Kyoko Nakamura
    Tomomi Kitaichi
    Yuko Maeno
    Teruhisa Tokunaga
    Akiko Fukuda
    Ichiro Koga
    [J]. Advances in Therapy, 2021, 38 : 4480 - 4504
  • [34] Safety and Effectiveness of Molnupiravir in Japanese Patients with COVID-19: Final Report of Post-marketing Surveillance in Japan
    Shinozaki S.
    Watanabe A.
    Kimata M.
    Miyazaki M.
    Maekawa S.
    [J]. Infectious Diseases and Therapy, 2024, 13 (1) : 189 - 205
  • [35] Safety Profile and Effectiveness of Rivaroxaban for Patients With Venous Thromboembolism in Japan - Results From Post-Marketing Surveillance (XASSENT) -
    Fukuda, Ikuo
    Hirayama, Atsushi
    Kawasugi, Kazuo
    Kobayashi, Takao
    Maeda, Hideaki
    Nakamura, Mashio
    Yamada, Norikazu
    Tajima, Tsubasa
    Tachiiri, Michiya
    Okayama, Yutaka
    Sunaya, Toshiyuki
    Hirano, Kazufumi
    Hayasaki, Takanori
    [J]. CIRCULATION JOURNAL, 2023, 87 (09) : 1175 - +
  • [36] Safety and Effectiveness Analysis of Dolutegravir in Patients with HIV-1: Interim Report of Post-Marketing Surveillance in Japan
    Hongo, Haruyuki
    Nagao, Takako
    Nakamura, Kyoko
    Kitaichi, Tomomi
    Maeno, Yuko
    Tokunaga, Teruhisa
    Fukuda, Akiko
    Koga, Ichiro
    [J]. ADVANCES IN THERAPY, 2021, 38 (08) : 4480 - 4504
  • [37] Safety and effectiveness of enzyme replacement therapy with agalsidase alfa in patients with Fabry disease: Post-marketing surveillance in Japan
    Sasa, Hiroaki
    Nagao, Munehiko
    Kino, Koichi
    [J]. MOLECULAR GENETICS AND METABOLISM, 2019, 126 (04) : 448 - 459
  • [38] Safety and effectiveness of Tadalafil on PAH from a post-marketing surveillance (Investigation on all patients in Japan, interim data)
    Xin, Ping
    Murakami, Masahiro
    Umeki, Yasuhiro
    Taketsuna, Masanori
    Kobayashi, Nobuyuki
    Yamazaki, Hiroyoshi
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (16) : C226 - C227
  • [39] Safety and effectiveness of istradefylline in patients with Parkinson's disease: interim analysis of a post-marketing surveillance study in Japan
    Takahashi, Makio
    Fujita, Masaki
    Asai, Naoko
    Saki, Mayumi
    Mori, Akihisa
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (15) : 1635 - 1642
  • [40] Safety and effectiveness of ustekinumab in Crohn's disease: Interim results of post-marketing surveillance in Japan
    Yokoyama, Seiji
    Asano, Teita
    Nagano, Katsumasa
    Tsuchiya, Hiroaki
    Takagishi, Masayuki
    Tsujioka, Shigeharu
    Miura, Naomi
    Matsumoto, Takayuki
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 (11) : 3069 - 3076
12345